Coronavirus disease 2019 (COVID-19) is known to present with respiratory symptoms,
which can lead to severe pneumonia and respiratory failure. However, it can have …

This review summarizes current trends in the use of MCS in CS and discusses differences in
CS management during the COVID-19 pandemic. Careful patient selection, early MCS …

Aims We assessed the outcome of hospitalized coronavirus disease 2019 (COVID‐19)
patients with heart failure (HF) compared with patients with other cardiovascular disease …

Heart failure exacerbations impart significant morbidity and mortality, however, large-scale
studies assessing outcomes in the setting of concurrent coronavirus disease-19 (COVID-19) …

Aims To study all‐cause mortality in patients hospitalized with COVID‐19 with or without
chronic heart failure (CHF) during hospitalization and at 3 and 6 months of follow‐up …

Background: The risk for worse outcomes of COVID-19 (Coronavirus 2019 disease) is
higher in patients with cardiac conditions. In this study, we aim to investigate the risks of …

The COVID pandemic has brought many new challenges worldwide, which has impacted on
patients with chronic conditions. There is an increasing evidence base suggesting an …

Cardiovascular diseases (CVD) are the most important cause of morbidity and mortality in
the general population. Because the high prevalence of COVID-19 and chronic Chagas …

Coronavirus disease 2019 (COVID-19) is associated with poor cardiovascular outcomes in
patients with heart failure (HF) of all categories of ejection fraction (EF), but mainly in …

Abstract The coronavirus disease 2019 (COVID-19) pandemic continues to pose a
significant threat to patients receiving advanced heart failure therapies. The current study …